- Report
- November 2023
- 262 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- December 2020
- 200 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- December 2024
- 82 Pages
Vietnam
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2021
- 24 Pages
Global
€1200EUR$1,318USD£1,028GBP
- Report
- November 2021
- 620 Pages
Global
From €3640EUR$4,000USD£3,121GBP
The Viral Antigen market is a subset of the Infectious Diseases Drugs market, which focuses on the development of treatments for viral infections. Viral antigens are molecules that are recognized by the immune system and can be used to diagnose and treat viral infections. These antigens can be used to create vaccines, which are used to prevent viral infections, or to create treatments that can be used to treat existing infections. Viral antigens can also be used to create diagnostic tests, which are used to detect the presence of a virus in a patient.
The Viral Antigen market is a rapidly growing field, with many companies investing in research and development to create new treatments and diagnostic tests. Companies in this market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more
